Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0JQUCB
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
WO2024110905A1 ADC-P1 BGB-C-269
|
|||||
| Synonyms |
WO2024110905A1 ADC-P1 BGB-C-269
Click to Show/Hide
|
|||||
| Organization |
BEIGENE, LTD. | BEIGENE SWITZERLAND GMBH
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
8.16
|
|||||
| Structure |
|
|||||
| Antibody Name |
undisclosed
|
|||||
| Antigen Name |
Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)
|
Antigen Info | ||||
| Payload Name |
ADC2-29 Payload
|
Payload Info | ||||
| Linker Name |
ADC-P1 BGB-C-269 Linker
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||